You just read:

Regeneron and Sanofi Announce FDA Approval of a New Once-Monthly Dosing Option for Praluent® (alirocumab) Injection

News provided by

Regeneron Pharmaceuticals, Inc.

Apr 25, 2017, 08:00 ET